Bharat Parenterals Ltd - Stock Valuation and Financial Performance

BSE: 541096 | NSE: | Pharmaceuticals & Drugs | Small Cap

Bharat Parenterals Share Price

1,150 24.40 2.17%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Bharat Parenterals

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Bharat Parenterals stock performance -

mw4me loader
P/E Ratio (SA):
22.67
Market Cap:
653.1 Cr.
52-wk low:
321.1
52-wk high:
1,464.9

Is Bharat Parenterals Ltd an attractive stock to invest in?

1. Is Bharat Parenterals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bharat Parenterals Ltd is a average quality company.

2. Is Bharat Parenterals Ltd undervalued or overvalued?

The key valuation ratios of Bharat Parenterals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Bharat Parenterals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bharat Parenterals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bharat Parenterals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bharat Parenterals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 16.6%13.5%10.7%9.7%11.3%23.2%22%14.4%12.9%8.9%-
Value Creation
Index
0.20.0-0.2-0.3-0.20.70.60.0-0.1-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 114119124111136220226204212218239
Sales YoY Gr.-4.5%4.5%-10.4%22.6%61.2%3%-10%4.1%2.8%-
Adj EPS 14.812.811.511.41436.342.434.336.129.249.5
YoY Gr.--13.5%-9.8%-1.6%23.6%158.8%16.6%-19.1%5.4%-19.1%-
BVPS (₹) 74.687.399112129.7169214.9250.5287.7329.9362.9
Adj Net
Profit
8.57.36.66.5820.824.319.620.916.929
Cash Flow from Ops. 7.79.40-1.96.320.314.521.9-22.1-11.6-
Debt/CF from Ops. 2.71.70-3.41.40.20.10.6-0.7-4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.5%9.8%-1.3%2.8%
Adj EPS 7.9%15.8%-11.6%-19.1%
BVPS18%20.5%15.4%14.7%
Share Price - 39.2% 50.3% 237.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
21.515.812.410.811.624.322.114.713.59.514.3
Op. Profit
Mgn %
89.28.36.39.713.813.412.313.81013.1
Net Profit
Mgn %
7.56.25.35.95.99.510.79.69.87.712
Debt to
Equity
0.50.30.30.10.10.100.10.10.2-
Working Cap
Days
174215220229223169200189199276152
Cash Conv.
Cycle
57484653827688819011352

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 14.30%

Sales growth is good in last 4 quarters at 34.52%

Sales growth has been subdued in last 3 years -1.25%

Net Profit has been subdued in last 3 years -11.63%

Latest Financials - Bharat Parenterals Ltd.

Standalone Consolidated
TTM EPS (₹) 49.5 29.7
TTM Sales (₹ Cr.) 239 241
BVPS (₹.) 362.9 340.4
Reserves (₹ Cr.) 205 192
P/BV 3.09 3.30
PE 22.67 37.84
From the Market
52 Week Low / High (₹) 321.05 / 1464.90
All Time Low / High (₹) 116.25 / 1464.90
Market Cap (₹ Cr.) 653
Equity (₹ Cr.) 5.8
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of Bharat Parenterals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Bharat Parenterals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales114119124111136220226204212218
Operating Expenses 105108114104123190197179184196
Manufacturing Costs336681212101115
Material Costs8286837988141147134136137
Employee Cost 77911121414141517
Other Costs 1211168152223202127
Operating Profit 911107133030252822
Operating Profit Margin (%) 8.0%9.2%8.0%6.3%9.6%13.7%13.2%12.3%13.4%9.9%
Other Income 2458713129819
Interest 1211111113
Depreciation 3446666676
Exceptional Items 0000000000
Profit Before Tax 6998143635272832
Tax 01314139778
Profit After Tax 7767102326202124
PAT Margin (%) 5.8%6.3%5.2%6.6%7.4%10.3%11.6%9.9%10.0%11.2%
Adjusted EPS (₹)11.413.011.312.917.639.445.935.336.942.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%2%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 435057647497123144166191
Share Capital 6666666666
Reserves 374451586991117138160185
Minority Interest0000000000
Debt2116194731101343
Long Term Debt412742119107
Short Term Debt1751305201336
Trade Payables29443936263243262348
Others Liabilities 8656233026171727
Total Liabilities 101116120110131161192196218308

Fixed Assets

Gross Block48536236445054717374
Accumulated Depreciation1924285101622283339
Net Fixed Assets29293531343432434035
CWIP 00000112010
Investments 0111132421638
Inventories16131415142128222138
Trade Receivables395844445966826873112
Cash Equivalents 4113241210257
Others Assets13141418192427196377
Total Assets 101116120110131161192196218308

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 890-26201422-22-12
PBT 6908143635272832
Adjustment 7606676651
Changes in Working Capital -6-40-14-11-12-17-4-49-36
Tax Paid 0-20-2-3-10-10-7-6-9
Cash Flow From Investing Activity -8-50-2-8-9-13-4122-14
Capex -9-50-2-8-9-151-55
Net Investments 00000-11-4127-22
Others 0001001003
Cash Flow From Financing Activity 6-70-84-4-311229
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000101-3
Interest Paid -1-20-1-1-1-10-1-2
Dividend Paid 0000000000
Others 7-50-75-3-21233
Net Cash Flow 5-20-1127-1-823
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)16.5816.0412.112.2114.5926.3823.9215.1613.7613.65
ROCE (%)13.6116.6515.2112.0919.1539.8331.6819.817.5916.62
Asset Turnover Ratio1.421.21.111.031.151.51.281.221.160.96
PAT to CFO Conversion(x)1.141.290-0.290.60.870.541.1-1.05-0.5
Working Capital Days
Receivable Days86137142136136103119115107134
Inventory Days51403845393039393342
Payable Days1011541831731307592946594

Bharat Parenterals Ltd Stock News

Bharat Parenterals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Bharat Parenterals on 28-Mar-2024 16:01 is ₹1,150.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Bharat Parenterals stood at ₹653.1.
The latest P/E ratio of Bharat Parenterals as of 28-Mar-2024 16:01 is 22.67.
The latest P/B ratio of Bharat Parenterals as of 28-Mar-2024 16:01 is 3.09.
The 52-week high of Bharat Parenterals is ₹1,464.9 and the 52-week low is ₹321.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bharat Parenterals is ₹239.5 ( Cr.) .

About Bharat Parenterals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.